AllianceBernstein’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-492,486
| Closed | -$18.6M | – | 3535 |
|
|
2021
Q1 | $18.6M | Buy |
492,486
+426,686
| +648% | +$10.6M | 0.01% | 954 |
|
|
2020
Q4 | $1.12M | Sell |
65,800
-9,300
| -12% | -$117K | ﹤0.01% | 2244 |
|
|
2020
Q3 | $353K | Hold |
75,100
| – | – | ﹤0.01% | 2723 |
|
|
2020
Q2 | $458K | Buy |
75,100
+11,500
| +18% | +$47.4K | ﹤0.01% | 2673 |
|
|
2020
Q1 | $144K | Buy |
63,600
+3,700
| +6% | +$15.7K | ﹤0.01% | 2887 |
|
|
2019
Q4 | $275K | Sell |
59,900
-500
| -0.8% | -$1.98K | ﹤0.01% | 2811 |
|
|
2019
Q3 | $234K | Hold |
60,400
| – | – | ﹤0.01% | 2888 |
|
|
2019
Q2 | $364K | Buy |
60,400
+10,500
| +21% | +$100K | ﹤0.01% | 2746 |
|
|
2019
Q1 | $669K | Sell |
49,900
-155,900
| -76% | -$1.78M | ﹤0.01% | 2418 |
|
|
2018
Q4 | $1.91M | Buy |
205,800
+155,900
| +312% | +$1.86M | ﹤0.01% | 1852 |
|
|
2018
Q3 | $695K | Hold |
49,900
| – | – | ﹤0.01% | 2487 |
|
|
2018
Q2 | $789K | Buy |
49,900
+2,880
| +6% | +$50.3K | ﹤0.01% | 2420 |
|
|
2018
Q1 | $808K | Buy |
47,020
+820
| +2% | +$16K | ﹤0.01% | 2354 |
|
|
2017
Q4 | $1.01M | Hold |
46,200
| – | – | ﹤0.01% | 2260 |
|
|
2017
Q3 | $1.89M | Hold |
46,200
| – | – | ﹤0.01% | 1883 |
|
|
2017
Q2 | $1.39M | Sell |
46,200
-51,570
| -53% | -$1.61M | ﹤0.01% | 2108 |
|
|
2017
Q1 | $3.53M | Buy |
97,770
+8,220
| +9% | +$362K | ﹤0.01% | 1408 |
|
|
2016
Q4 | $4.49M | Sell |
89,550
-18,200
| -17% | -$956K | ﹤0.01% | 1258 |
|
|
2016
Q3 | $5.66M | Buy |
107,750
+24,250
| +29% | +$1.16M | ﹤0.01% | 1074 |
|
|
2016
Q2 | $3.45M | Buy |
83,500
+48,760
| +140% | +$2.12M | ﹤0.01% | 1265 |
|
|
2016
Q1 | $1.41M | Buy |
34,740
+7,340
| +27% | +$252K | ﹤0.01% | 1877 |
|
|
2015
Q4 | $1.14M | Buy |
27,400
+8,600
| +46% | +$288K | ﹤0.01% | 2049 |
|
|
2015
Q3 | $289K | Buy |
18,800
+3,300
| +21% | +$70.9K | ﹤0.01% | 2671 |
|
|
2015
Q2 | $385K | Buy |
15,500
+7,500
| +94% | +$167K | ﹤0.01% | 2678 |
|
|
2015
Q1 | $183K | Buy |
8,000
+6,800
| +567% | +$172K | ﹤0.01% | 2865 |
|
|
2014
Q4 | $32K | Hold |
1,200
| – | – | ﹤0.01% | 3162 |
|
|
2014
Q3 | $14K | Sell |
1,200
-1,200
| -50% | -$15.1K | ﹤0.01% | 3247 |
|
|
2014
Q2 | $37K | Buy |
+2,400
| New | +$34.4K | ﹤0.01% | 3155 |
|
AllianceBernstein's FPRX Position: Q2 2021 in Review
AllianceBernstein sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 492,486 shares — an estimated $18.6M sold.
AllianceBernstein first reported a position in FPRX in Q2 2014 and held it in 28 quarters. The position peaked at $18.6M in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.
- AllianceBernstein reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
- AllianceBernstein sold 492,486 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $18.6M.
- AllianceBernstein first reported a position in Five Prime Therapeutics, Inc. in Q2 2014 and held it in 28 quarters.
- AllianceBernstein's Five Prime Therapeutics, Inc. position peaked at $18.6M in Q1 2021.
- 0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.
Based on AllianceBernstein's 13F filing for Q2 2021, filed 30 Jul 2021.